COVID-19: ‘BCG Japanese strain’ vaccinated countries: Japan, Taiwan, low mortality
COVID-19:
Why is “there are few COVID-19 deaths in Japan and Taiwan?”
COVID-19: Number of deaths
There was a big difference in the mortality rate of the new corona with and without the inoculation of TB vaccine “BCG”.
Among them, the mortality rate of the country inoculated with the “Japanese strain” spread from Japan is extremely low.
Magazine AERA: May 18, 2020 issue
We approached the forefront of viruses and immunity with the May 18, 2020 issue of AERA.
BCG Japanese shares and Soviet shares are close to “former shares”.
At this stage, it can only be said that the correlation can be seen, but it means “there is still a very strong correlation“.
New York Institute of Technology: Researcher
At the end of March, a paper appeared that concluded that “BCG vaccine plays a role of protection against the new corona”.
We investigated the ratio of the number of infected and dead people of new corona in each country and the vaccination status of BCG vaccine.
Immunology Frontier Research Center, Osaka University:
Professor Masayuki Miyasaka points out that.
Infection rate and mortality rate: Country survey
Non-vaccinated countries such as Italy, Belgium, and the United States were statistically significantly higher than those receiving vaccination.
Miyasaka, who continues to follow the relationship between BCG vaccination and the infection and mortality of the new corona, says.
“If we look at the number of deaths per million people, the correlation is clearer.”
The number of deaths per million people：
Countries that have never been vaccinated
227 in the United States,
Italy has 490 people.
Countries that have been vaccinated in the past but are not currently vaccinated
France 396,
Spain 553 people.
Countries widely inoculated with BCG
3.2 people in China,
Korea has 5.0
There are 4.4 in Japan.
0.3 in Taiwan
(All as of May 7)
The death toll between Taiwan and Spain is more than 1800 times greater.
(AERA dot.)
https://headlines.yahoo.co.jp/article?a=20200513-00000016-sasahi-hlth&p=1
TB Vaccine Could Be a Valuable Weapon in COVID-19 Fight MARCH 30, 2020
The tuberculosis (TB) vaccine,Bacillus Calmette-Guerin (BCG),
could be a potential weapon in combatting the deadly coronavirus according to findings published by NYIT College of Osteopathic Medicine (NYITCOM) researchers,led by Gonzalo Otazu, Ph.D., assistant professor of biomedical sciences.
The United States currently leads the world in confirmed COVID-19 cases, followed by Italy, per the latest report from Johns Hopkins University’s Center for Systems Science and Engineering (CSSE).
Now NYITCOM researchers propose that
the severity of COVID-19 impact may be linked to varying national policies on BCG childhood vaccination.
“We found that countries without universal policies of BCG vaccination, such as
- Italy,
- the Netherlands, and
- the United States
have been more severely affected compared to countries with universal and long-standing BCG policies,” the researchers state.
According to the study, made widely available by MedRXiv, a combination of reduced morbidity and mortality could make the BCG vaccination a game-changer in the fight against COVID-19.
As one of the most widely used vaccines in the world, the BCG vaccine
has existed for nearly a century and has been shown to be an effective tool in preventing meningitis and disseminated TB in children.
The inoculation is also believed to offer broad-ranging protection against respiratory infections, which present similar symptoms to COVID-19.
In fact, Australian researchers have just announced plans to fast track large-scale testing to see if the BCG vaccination can protect health workers from the coronavirus.
| Box | NYIT
https://www.nyit.edu/box/features/tb_vaccine_could_be_a_valuable_weapon_in_covid_19_fight